Elicio Therapeutics Inc.

ELTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.85

-$0.06 (-3.14%)

Sep 22, 2026, 11:24 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-39.57M	-51.9M	-35.2M	-28.21M	-26.4M	-80.11M
Depreciation & Amortization	1.13M	1.18M	1.17M	1.06M	251.45K	628K
Stock-Based Compensation	2.7M	1.45M	1.18M	579K	617.76K	n/a
Other Working Capital	-3.08M	7.29M	-80K	-1.28M	842.21K	30.94M
Other Non-Cash Items	2.24M	8.24M	209K	4.54M	667.05K	30.82M
Deferred Income Tax	n/a	n/a	n/a	n/a	52.96K	n/a
Change in Working Capital	-3.45M	3.96M	-57K	-150K	872.44K	25.77M
Operating Cash Flow	-36.95M	-37.07M	-32.69M	-22.18M	-23.94M	-22.89M
Capital Expenditures	-16K	-87K	-66K	-654K	-525.36K	-41K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	3K	34K	n/a	n/a	n/a
Investing Cash Flow	-16K	-84K	-32K	-654K	-525.36K	-41K
Debt Repayment	9.87M	19.73M	10M	n/a	14.03M	32.12M
Common Stock Repurchased	n/a	n/a	-150K	n/a	n/a	-36K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	16.96M	21.76M	82K	314.88K	n/a
Financial Cash Flow	36.7M	42.32M	38.61M	21.2M	19.39M	52.41M
Net Cash Flow	-233K	5.19M	5.89M	-80.96M	-5.07M	29.04M
Free Cash Flow	-36.97M	-37.16M	-32.76M	-22.83M	-24.46M	-22.93M
Adj. Free Cash Flow	-39.67M	-38.61M	-33.94M	-23.41M	-25.08M	-22.93M
Maintenance CapEx	-16K	-87K	-66K	-654K	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-525.36K	-41K
Owner Earnings	-36.97M	-37.16M	-32.76M	-22.83M	-23.94M	-22.89M